Haier Biomedical
Corporate brand
UnclaimedHaier Biomedical is a manufacturer of cold chain equipment covering the full range of -196°C to +8°C and a digital scenario solution provider in life science and medical innovation.
Last updated October 9, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Haier Biomedical was founded to focus on the research & development, manufacturing, and sales of low-temperature storage equipment for biomedical samples. Based on the concept of IoT, the company has become a digital scenario solution provider in life science and medical innovation, delivering comprehensive digital scenario solutions such as smart lab, digital hospital, smart public health, and smart blood use to user groups including hospitals, bio-pharmaceutical enterprises, universities & colleges, scientific research institutions, centers for disease control, and blood stations. Since 2005, it has been dedicated to promoting technological innovation and developing biomedical cryogenic technology, and it participated in creating 32 national, industry, and group standards.
History
Haier Biomedical was founded to focus on the research & development, manufacturing, and sales of low-temperature storage equipment for biomedical samples. Based on the concept of IoT, the company has become a digital scenario solution provider in life science and medical innovation. Since 2005, Haier Biomedical has been dedicated to promoting technological innovation and leading the industry as a technology leader. By developing biomedical cryogenic technology, the company has become a new international manufacturer in the global market. As a result, the company won the China's only National Prize for Progress in Science and Technology within this industry, and participated in creating 32 national, industry, and group standards to promote the standardized development of the industry. To stay competitive in the digital economy era, Haier Biomedical has integrated IoT, automation, and other emerging technologies, and launched comprehensive digital scenario solutions, such as smart blood use and smart vaccination.
- 2005
Haier Biomedical begins dedicated work in biomedical cryogenic technology and low-temperature storage equipment, positioning itself as a technology leader in the industry.
The company develops its IoT-based digital scenario solutions, including the U-Blood Network, U-Laboratory Network, U-Vaccine Network, U-Reagent Network, and U-Biobank Network.
Haier Biomedical wins China's only National Prize for Progress in Science and Technology within its industry and participates in creating 32 national, industry, and group standards.
Products and positioning
Digital scenario solution provider in life science and medical innovation; complete cold chain manufacturer covering the full range of -196°C to +8°C.
U-Blood Network IoT Intelligent Blood Safety Management
Provides a unified and secure systemized platform for the entire city's blood supply, linking IoT with the data management system and building blood information that interconnects between the city's central blood bank and blood usage at each of the hospitals.
U-Laboratory Network
Provides protection solutions for operators, samples, and the environment from site evaluation and layout planning before laboratory construction to standardized infrastructure design, supporting biological safety cabinets, clean benches, spark free refrigerators and other product solutions during laboratory construction.
U-Vaccine Network
Addresses vaccine incidents such as problematic vaccines, expired vaccines, and mistyped vaccines, which have exposed problems such as lack of intelligent vaccination and unscientific and unregulated vaccine regulation.
U-Reagent Network
Based on the application of intelligent IoT technology on medical refrigerated products, realizes real time information track of each term in storage and fully automatic and intelligent management of reagents and medicines.
U-Biobank Network
In the area of biobanks, through the combination of cryogenic storage and IoT manage system, realizes the three-way real-time interaction.
Recent events
Reported
Resonant Clinical Solutions and Haier Biomedical launch LX-60T100R natural-refrigerant benchtop centrifuge[5]
Resonant Clinical Solutions and Haier Biomedical jointly launched the LX-60T100R, a benchtop centrifuge designed for clinical trials that uses natural hydrocarbon refrigerant R290 instead of F-gases, cutting refrigerant GWP from over 1,400 to about 3. It reached the market more than two years ahead of key F-gas compliance deadlines in Europe and the US. From now until November 2027, clinical trial sponsors and CROs can buy or lease it exclusively through Resonant in global clinical trial markets outside China; the 220-240 V model is available now and a 110 V model is due in Q1 2027.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/haier-biomedical · Editorial policy · How profiles are compiled